The TV channel reported, the Drug Regulatory Authority on Thursday issued the SRO to reduce the price of the antiviral drug. As per the Statutory Regulatory Orders (SRO), the price of Remdesivir 100mg per solution has been fixed at Rs 5,680. The SRO has been issued after the Federal Cabinet had approved the reduction in the price of the drug,
Earlier, the price of a pack of 100mg powder and solution was fixed at Rs 9,244.
The DRAP fixed the price of the drug on October 27 and issued an SRO. There will be two conditions for obtaining the prescribed MRP of Remdesivir, the TV channel reported. DRAP importers will be required to submit the Maximum Retail Price MRP of the drug to DRAP’s Casting and Pricing Division.
The DRAP will print the MRP on the label of the packet under the Drug Labeling and Packing Rules 1986. The Drug Regulatory Authority had issued a formal advisory in this regard. “Emergency use of Remdesivir has been allowed,” the TV channel reported.
Mercuria, a global commodities trading firm headquartered in Geneva, finds its senior executives under scrutiny…
Pakistan Stock Exchange (PSX) remained bullish for the second session in a row on Monday,…
The rupee remained on the back foot against the US dollar in the interbank market…
The Securities and Exchange Commission of Pakistan has approved the Scheme of Arrangement between Pakistan…
Gold price in the country snapped a six-session losing streak and increased by Rs2,500 per…
Chairman of the Prime Minister Youth’s Programme(PMYP) Rana Mashhood has underscored the success of the…
Leave a Comment